CJM112
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CJM112, covering 2019-05-23 to 2020-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma [Phase 2]